So much so, analysts at Jefferies says the industry could reach $130 billion by 2029.

“This assumes full U.S. federal legalization, full recreational and medical legalization across Europe, full medical and recreational legalization across Lat Am, and cannabis disruption of a number of other industries,” noted the analysts, as quoted by Yahoo Finance. “Industries at risk of disruption are pharma, alcohol, health and wellness, pet care and smoking cessation.”

The analysts join a growing chorus of cannabis bullishness.

Cowen for example says U.S. cannabis sales alone could reach $80 billion by 2030 – an increase of $5 billion from earlier estimates, and a 4% compound annual growth rate.  Piper Jaffray believes the market for legal cannabis could be worth $15 billion to $50 billion a year, with global sales growing to $250 billion to $500 billion.

Of course, that can lead to further upside for stocks that do so, including Blissco Cannabis Corp. (CSE: BLIS) (OTCQB: HSTRF), OrganiGram Holdings Inc. (OTC:OGRMF), and CannTrust Holdings Inc. (NYSE:CTST) (TO:TRST).

Blissco Cannabis Corp. (BLIS) (HSTRF), a Canadian wellness cannabis brand based in British Columbia and a multi-licensed processor, cultivator and distributor of premium cannabis, just announced that it earned Depository Trust Company (DTC) eligibility. That means its stock is now more accessible to U.S. investors.

“We are very excited to be DTC eligible; which opens up a tremendous opportunity for U.S. investors to participate in our growth,” said Damian Kettlewell, Blissco CEO. “Blissco is truly beginning to make its mark in domestic and international markets by expanding our global investor base.”

This electronic method of clearing securities speeds up the receipt of stock and cash, and accelerates the settlement process for investors and brokers. Companies that are DTC eligible often experience higher trading volumes in their stock given the additional accessibility and availability of shares for trading.

Another stock to watch for potential listing on a major exchange is OrganiGram Holdings (OTC:OGRMF), which produces and sells medical marijuana in Canada. The company is ramping up production to capitalize on new market opportunities as an existing licensed producer. An active expansion includes a 15,000 sq. ft. extract processing facility that could prove quite useful, as the cannabis market progresses.

The company also just signed a letter of intent with the Société québécoise du cannabis (SQDC). With it, the company now has distribution in place for all ten Canadian provinces.

“Organigram’s growth strategy has always focused on establishing a strong national footprint and building our brand presence with the Edison Cannabis line nationally,” says OGRMF CEO Greg Engel. “We are proud to work with our partners across the country to help ensure Canadians have access to a reliable supply of premium cannabis products for both medical and adult recreational use. We look forward to continuing to build on these relationships as we look ahead to the legalization of cannabis edibles.”

CannTrust Holdings (CTST) (TRST), which produces and distributes pharmaceutical grade medical cannabis products in Canada just listed on the NYSE, as of February 25, 2019 under the ticker symbol, “CTST.” It will also still list on the Toronto Stock Exchange under “TRST.”

“CannTrust has firmly established itself as one of the top licensed producers in Canada with a global platform rooted in trust, science and innovation," CannTrust CEO Peter Aceto said. "A listing on the NYSE is a natural step forward in our evolution as we look to broaden our investor base, increase the company's exposure and expand our business on an international scale."

MarijuanaStox.com is a leading web destination for all cannabis related companies. Investors can also find current marijuana-related quality financial, medical, legal and social news.

MarijuanaStox.com is a media agency in North America dedicated to the cannabis industry, helping companies that operate in the space to attract quality investors, working capital and real publicity. Since 2005, we have had public companies in the US and Canada have rely on us to grow and succeed.